Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Pulido, F.
space
  arrow  Costa, J. R.
space
 arrow  PubMed                        
space

LETTER

Neurologic Manifestations of HIV Infection

right arrow Federico Pulido; Rafael Rubio; and J. Ramon Costa

1 June 1995 | Volume 122 Issue 11 | Pages 883-884


TO THE EDITOR:

We disagree with Simpson and Tagliati [1], who favor a presumptive diagnosis and empiric treatment of neurosyphilis in patients with HIV infection, neurologic symptoms, and a reactive cerebrospinal profile only when a positive serum VDRL test result is obtained.

Patients with HIV infection frequently have false-positive reaginic test results for syphilis. The problem is greater when these patients are intravenous drug users. In these persons, false-positive reaginic results appear in 25% of cases [2].

We found that a reaginic test had a positive predictive value for syphilis of 27% when it was done in a population of HIV-infected patients, 78% of whom were drug users. Seventy-four of 367 (20%) HIV-infected patients studied in our university hospital had a false-positive test result.

These results support the recommendation that therapy should not be initiated without confirmation by a treponemic test.


References
space
up arrowTop
dotReferences

1. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med. 1994; 121:769-85.

2. Pulido F, Rubio R, Salmeron OJ, Castilla V, Carnevali D, Costa JR, et al. Reactividad de las pruebas serologicas para deteccion de sfilis en pacientes infectados por el virus de la immunodeficiencia humana. Med Clin (Barcelona). 1993; 101:365-7.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Pulido, F.
space
  arrow  Costa, J. R.
space
 arrow  PubMed                        
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online